semaglutide salt compound | C187H291N45O59 | CID 56843331 Semaglutide Sublingual 1mg/ml | NextGenRx
Description
CagriSema (from Novo Nordisk) combines cagrilintide and semaglutide in a single injection
The primary advantage of compounding is flexibility and cost
Patients should be encouraged to prioritize nutrient-dense foods and ensure adequate protein intake (typically 1.2-1.6 g/kg of ideal body weight daily during active weight loss, with higher amounts for those engaging in resistance training)
These effects are generally mild with the starting dose and tend to be self-limiting
Choose from injection or oral formulations based on your preference
A doctor must be consulted before use in these situations
